Screener
Inhibrx Biosciences, Inc. INBX Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0002007919-26-000027
| Line item | MARCH 31, 2026 | DECEMBER 31, 2025 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $161,657 | $124,220 |
| Other receivables | 186 | 177 |
| Prepaid expenses and other current assets | 9,498 | 8,435 |
| Total current assets | 171,341 | 132,832 |
| Property and equipment, net | 3,196 | 3,733 |
| Operating right-of-use asset | 5,052 | 5,535 |
| Other non-current assets | 4,378 | 4,378 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Inhibrx Biosciences, Inc.'s prepaid & other current?
- Inhibrx Biosciences, Inc. (INBX) reported prepaid & other current of $9.5M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s prepaid & other current changed year-over-year?
- Inhibrx Biosciences, Inc.'s prepaid & other current increased by 42.8% year-over-year, from $6.65M to $9.5M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Inhibrx Biosciences, Inc.'s prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude